{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T22:36:32Z","timestamp":1768170992605,"version":"3.49.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.clon.2009.07.003","type":"journal-article","created":{"date-parts":[[2009,8,4]],"date-time":"2009-08-04T05:23:28Z","timestamp":1249363408000},"page":"575-590","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Radiotherapy in England in 2007: Modelled Demand and Audited Activity"],"prefix":"10.1016","volume":"21","author":[{"given":"M.V.","family":"Williams","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.J.","family":"Drinkwater","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clon.2009.07.003_bib1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.clon.2007.03.011","article-title":"Radiotherapy dose fractionation, access and waiting times in the countries of the UK in 2005","volume":"19","author":"Williams","year":"2007","journal-title":"Clin Oncol"},{"key":"10.1016\/j.clon.2009.07.003_bib2","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0360-3016(00)01401-2","article-title":"Estimating the need for radiotherapy for lung cancer: an evidence-based epidemic approach","volume":"49","author":"Tyldesley","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2009.07.003_bib3","series-title":"Radiotherapy in cancer care; estimating optimal utilisation from a review of evidence-based clinical guidelines","author":"Delaney","year":"2003"},{"key":"10.1016\/j.clon.2009.07.003_bib4","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/cncr.21324","article-title":"The role of radiotherapy in cancer treatment: estimating optimal utilisation from a review of evidence-based clinical guidelines","volume":"104","author":"Delaney","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.clon.2009.07.003_bib5","series-title":"Cancer in Scotland: radiotherapy activity planning 2011\u201315","author":"The Scottish Government","year":"2005"},{"key":"10.1016\/j.clon.2009.07.003_bib6","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/j.ejca.2007.05.022","article-title":"What will be the radiotherapy machine capacity required for optima delivery of radiotherapy in Scotland in 2015?","volume":"43","author":"Erridge","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clon.2009.07.003_bib7","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.radonc.2004.12.007","article-title":"Towards evidence-based guidelines for radiotherapy infrastructure and staffing needs in Europe: ESTRO QUARTS Project","volume":"75","author":"Bentzen","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2009.07.003_bib8","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1038\/sj.bjc.6603746","article-title":"The future burden of cancer in England: incidence and numbers of new patients in 2020","volume":"96","author":"Moller","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clon.2009.07.003_bib9","author":"Department of Health"},{"key":"10.1016\/j.clon.2009.07.003_bib10","author":"Department of Health"},{"key":"10.1016\/j.clon.2009.07.003_bib11","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/02841860310011131","article-title":"A prospective survey of radiotherapy practice in 2001 in Sweden","volume":"42","author":"Moller","year":"2003","journal-title":"Acta Oncol"},{"key":"10.1016\/j.clon.2009.07.003_bib12","author":"Drinkwater"},{"key":"10.1016\/j.clon.2009.07.003_bib13","author":"Summers"},{"key":"10.1016\/j.clon.2009.07.003_bib14","author":"Department of Health"},{"key":"10.1016\/j.clon.2009.07.003_bib15","series-title":"Cancer Reform Strategy","author":"Department of Health","year":"2007"},{"key":"10.1016\/j.clon.2009.07.003_bib16","author":"Welsh Assembly Government"},{"key":"10.1016\/j.clon.2009.07.003_bib17","author":"National Cancer Services Analysis Team (Natcansat)"},{"key":"10.1016\/j.clon.2009.07.003_bib18","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(05)66984-X","article-title":"Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial","volume":"366","author":"Oliver","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.clon.2009.07.003_bib19","series-title":"Radiotherapy dose-fractionation","author":"The Royal College of Radiologists","year":"2006"},{"key":"10.1016\/j.clon.2009.07.003_bib20","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1470-2045(08)70077-9","article-title":"The UK standardisation of breast radiotherapy (START) trial A of radiotherapy hypo-fractionation for treatment of early breast cancer: a randomised trial","volume":"9","author":"The START Trialists' Group","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clon.2009.07.003_bib21","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/S0140-6736(08)60348-7","article-title":"The UK standardisation of breast radiotherapy (START) trial B of radiotherapy hypo-fractionation for treatment of early breast cancer: a randomised trial","volume":"371","author":"The START Trialists' Group","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.clon.2009.07.003_bib22","doi-asserted-by":"crossref","first-page":"a2843","DOI":"10.1136\/bmj.a2843","article-title":"Adjuvant radiotherapy for breast cancer","volume":"337","author":"Hiley","year":"2008","journal-title":"Br Med J"},{"key":"10.1016\/j.clon.2009.07.003_bib23","series-title":"National head and neck cancer audit. DAHNO third annual report","author":"The Information Centre","year":"2008"},{"key":"10.1016\/j.clon.2009.07.003_bib24","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0167-8140(03)00059-8","article-title":"Three weeks' radiotherapy for T1 glotic cancer: the Christie and Royal Marsden Hospital experience","volume":"68","author":"Gowda","year":"2003","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2009.07.003_bib25","series-title":"The diagnosis and treatment of lung cancer","author":"National Institute for Clinical Excellence","year":"2005"},{"key":"10.1016\/j.clon.2009.07.003_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002140.pub2","article-title":"Synchronous chemoradiotherapy in non-small cell lung cancer","author":"Rowell","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clon.2009.07.003_bib27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.clon.2005.10.002","article-title":"National survey of radiotherapy fractionation practice in 2003","volume":"18","author":"Williams","year":"2006","journal-title":"Clin Oncol"},{"key":"10.1016\/j.clon.2009.07.003_bib28","article-title":"Chemotherapy for non-small cell lung cancer","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clon.2009.07.003_bib29","series-title":"National lung cancer audit, 2006","author":"The Information Centre","year":"2007"},{"key":"10.1016\/j.clon.2009.07.003_bib30","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1136\/thx.2005.040477","article-title":"Lung cancer in Teesside (UK) and Varese (Italy): a comparison of management and survival","volume":"61","author":"Imperatori","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.clon.2009.07.003_bib31","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.clon.2007.10.008","article-title":"Question of dose-fractionation and technique: ingredients for testing hypo fractionation in prostate cancer \u2013 the CHHiP trial","volume":"20","author":"Khoo","year":"2008","journal-title":"Clin Oncol"},{"key":"10.1016\/j.clon.2009.07.003_bib32","series-title":"Prostate cancer: diagnosis and treatment","author":"National Institute for Health and Clinical Excellence","year":"2008"},{"key":"10.1016\/j.clon.2009.07.003_bib33","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.clon.2008.09.002","article-title":"Hypo fractionation in prostate cancer: how far can we go?","volume":"20","author":"Hoskin","year":"2008","journal-title":"Clin Oncol"},{"key":"10.1016\/j.clon.2009.07.003_bib34","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.clon.2008.08.006","article-title":"Phase I\/II study of 5-fraction hypofractionated accelerated radiotherapy treatment for low-risk localised prostate cancer: early results of pHART 3","volume":"20","author":"Tang","year":"2008","journal-title":"Clin Oncol"},{"key":"10.1016\/j.clon.2009.07.003_bib35","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.clon.2008.04.017","article-title":"Locally advanced non-metastatic cancer \u2013 can we do more?","volume":"20","author":"Hawkins","year":"2008","journal-title":"Clin Oncol"},{"key":"10.1016\/j.clon.2009.07.003_bib36","author":"National Cancer Institute"},{"key":"10.1016\/j.clon.2009.07.003_bib37","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/sj.bjc.6603719","article-title":"Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation\/combined modality therapy","volume":"96","author":"Sultana","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clon.2009.07.003_bib38","first-page":"5","article-title":"Comparative therapeutic trial of radiation with or without chemotherapy in pancreatic cancer","volume":"9","author":"Gastrointestinal Tumour Study Group","year":"1979","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2009.07.003_bib39","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/jnci\/80.10.751","article-title":"Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone","volume":"80","author":"Gastrointestinal Tumour Study Group","year":"1988","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clon.2009.07.003_bib40","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1200\/JCO.1997.15.6.2403","article-title":"Improvements in survival and clinical benefit for gemcitabine as first-line therapy for patients with advanced pancreatic cancer: a randomised trial","volume":"15","author":"Burris","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2009.07.003_bib41","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1056\/NEJMoa032295","article-title":"A randomised trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer","volume":"350","author":"Neoptolemos","year":"2004","journal-title":"N Eng J Med"},{"key":"10.1016\/j.clon.2009.07.003_bib42","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ijrobp.2004.11.018","article-title":"A challenge to the therapeutic nihilism of ESPAC-1","volume":"61","author":"Koshy","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2009.07.003_bib43","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1001\/jama.299.9.1019","article-title":"Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial","volume":"299","author":"Regine","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.clon.2009.07.003_bib44","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1093\/annonc\/mdn281","volume":"19","author":"Chauffert","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clon.2009.07.003_bib45","author":"NCRI Upper GI Clinical Studies Group"},{"key":"10.1016\/j.clon.2009.07.003_bib46","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0140-6736(09)60484-0","article-title":"Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG CO16): a randomised clinical trial","volume":"373","author":"Sebag-Montefiore","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.clon.2009.07.003_bib47","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0140-6736(09)60485-2","article-title":"Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial","volume":"373","author":"Quirke","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.clon.2009.07.003_bib48","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S0140-6736(09)60459-1","article-title":"Rectal cancer: optimum treatment leads to optimum results","volume":"373","author":"Madoff","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.clon.2009.07.003_bib49","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.clon.2007.07.004","article-title":"Is there a role for radiotherapy in operable rectal cancer?","volume":"19","author":"Craven","year":"2007","journal-title":"Clin Oncol"},{"key":"10.1016\/j.clon.2009.07.003_bib50","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.clon.2009.01.004","article-title":"UK third national colorectal cancer consensus meeting 2008","volume":"21","author":"Glynne-Jones","year":"2009","journal-title":"Clin Oncol"},{"key":"10.1016\/j.clon.2009.07.003_bib51","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.clon.2007.03.013","article-title":"Defining the need to breast cancer radiotherapy in the general population: the criterion based bench marking approach","volume":"19","author":"Kerba","year":"2007","journal-title":"Clin Oncol"},{"key":"10.1016\/j.clon.2009.07.003_bib52","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijrobp.2006.03.059","article-title":"Effective distance to radiation treatment facility on use of radiation therapy after mastectomy in elderly women","volume":"66","author":"Punglia","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2009.07.003_bib53","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/cncr.21557","article-title":"Treatment of local breast carcinoma in Florida: the role of distance to radiation treatment therapy facilities","volume":"106","author":"Voti","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.clon.2009.07.003_bib54","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.ejca.2008.02.001","article-title":"Travel time to hospital and treatment for breast, colon, rectum, lung, ovary, prostate cancer","volume":"44","author":"Jones","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clon.2009.07.003_bib55","series-title":"Guidance on the development and management of devolved radiotherapy services","author":"The Royal College of Radiologists","year":"2004"},{"key":"10.1016\/j.clon.2009.07.003_bib56","author":"National Cancer Services Analysis Team (Natcansat)"},{"key":"10.1016\/j.clon.2009.07.003_bib57","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.clon.2009.05.006","article-title":"Geographical variation in radiotherapy services across the UK in 2007 and the impact of deprivation","volume":"21","author":"Williams","year":"2009","journal-title":"Clin Oncol"},{"key":"10.1016\/j.clon.2009.07.003_bib58","series-title":"Towards safer radiotherapy","author":"Royal College of Radiologists","year":"2008"},{"key":"10.1016\/j.clon.2009.07.003_bib59","series-title":"Breaking the mould: roles, responsibilities and skills mix in departments of clinical oncology","author":"The Royal College of Radiologists","year":"2002"},{"key":"10.1016\/j.clon.2009.07.003_bib60","series-title":"A strategy for the education and professional development of radiographers","author":"College of Radiographers","year":"2002"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655509001964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655509001964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:34:35Z","timestamp":1760542475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655509001964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":60,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0936655509001964"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2009.07.003","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiotherapy in England in 2007: Modelled Demand and Audited Activity","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2009.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}